# Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma

> **NCT05546853** · PHASE1 · COMPLETED · sponsor: **University Hospital, Grenoble** · enrollment: 43 (actual)

## Conditions studied

- Pancreatic Ductal Adenocarcinoma

## Interventions

- **DRUG:** NP137
- **DRUG:** Oxaliplatin
- **DRUG:** Irinotecan
- **DRUG:** Calcium levofolinate
- **DRUG:** 5 FU

## Key facts

- **NCT ID:** NCT05546853
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-28
- **Primary completion:** 2024-12-09
- **Final completion:** 2025-06-16
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2026-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05546853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05546853, "Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05546853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*